Drug Profile
Allergy immunotherapy sublingual - Stallergenes Greer plc
Alternative Names: Staloral; STALORAL 300 IR; Staloral Grass 300; Staloral Mites 300Latest Information Update: 17 Sep 2021
Price :
$50
*
At a glance
- Originator Stallergenes SA
- Developer Stallergenes Greer plc
- Class Allergy immunotherapies; Antiallergics
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Allergic asthma; Allergic rhinitis
Most Recent Events
- 07 Jul 2021 Launched for Allergic asthma in Hungary (Sublingual)
- 30 Jan 2021 Launched for Allergic asthma in Czech Republic (Sublingual)
- 15 Jul 2020 Launched for Allergic asthma in Russia (Sublingual)